☆ 4.2 Article

Long-term efficacy of the sublingual and subcutaneous routes in allergen immunotherapy

ALLERGY AND ASTHMA PROCEEDINGS (2022)

Related references

Note: Only part of the references are listed.

Article Allergy

Future directions in allergen immunotherapy

Harold S. Nelson

Summary: Both subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) are effective treatments for allergic rhinitis and allergic asthma, but many potential beneficiaries do not choose these treatments due to safety concerns and inconvenience. Shortening the duration of allergen immunotherapy and improving its efficacy and safety have been studied extensively, with several approaches showing promise for potential use in the next few years, including intralymphatic and epicutaneous immunotherapy, vitamin D supplementation for patients with insufficient levels, probiotics, and allergoids.

ALLERGY AND ASTHMA PROCEEDINGS (2022)

Add to Collection

Article Allergy

Mechanisms and biomarkers of subcutaneous immunotherapy and sublingual immunotherapy in allergen immunotherapy

Tiak Ju Tan et al.

Summary: There is currently a lack of reliable biomarkers for predicting clinical outcomes in allergen immunotherapy. Identifying key areas of development for biomarkers and their feasibility in clinical use is important. Most biomarkers are not yet feasible for translation to the clinical setting, and further research is needed. Exploration of integrative biomarkers may be necessary for predicting outcomes of allergen immunotherapy.

ALLERGY AND ASTHMA PROCEEDINGS (2022)

Add to Collection

Article Allergy

A brief history of allergen immunotherapy

Ira Finegold

Summary: This article reviews the progress made by individuals who have contributed to the science of allergen immunotherapy.

ALLERGY AND ASTHMA PROCEEDINGS (2022)

Add to Collection

Article Allergy

A 300 IR sublingual tablet is an effective, safe treatment for house dust mite?induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trial

Pascal Demoly et al.

Summary: The study evaluated the efficacy and safety of a 300 index of reactivity sublingual tablet for allergic rhinitis induced by house dust mites, showing significant improvement in symptoms and good tolerability. This treatment is proven to be effective and safe for patients with moderate to severe allergic rhinitis.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Add to Collection

Article Allergy

Disease-Modifying Effect of Japanese Cedar Pollen Sublingual Immunotherapy Tablets

Syuji Yonekura et al.

Summary: Japanese cedar pollen SLIT tablets demonstrated sustained clinical efficacy over 5 years, with the AA group showing the largest relative reduction in total nasal symptom and medication score. The treatment also exhibited disease-modifying effects for at least 2 years post-cessation.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)

Add to Collection

Article Allergy

Primary prevention of asthma in high risk children using HDM SLIT: Assessment at age 6 years

Cherry Alviani et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

Add to Collection

Review Allergy

Perspectives in allergen immunotherapy: 2019 and beyond

Oliver Pfaar et al.

ALLERGY (2019)

Add to Collection

Article Allergy

Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy

Erkka Valovirta et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)

Add to Collection

Article Allergy

EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis

G. Roberts et al.

ALLERGY (2018)

Add to Collection

Article Medicine, General & Internal

Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis The GRASS Randomized Clinical Trial

Guy W. Scadding et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)

Add to Collection

Article Medicine, General & Internal

Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma A Randomized Clinical Trial

J. Christian Virchow et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)

Add to Collection

Review Allergy

Sublingual or subcutaneous immunotherapy for allergic rhinitis?

Stephen R. Durham et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)

Add to Collection

Article Allergy

Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial

Pascal Demoly et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)

Add to Collection

Article Allergy

Prolonged efficacy of the 300IR 5-grass pollen tablet up to 2 years after treatment cessation, as measured by a recommended daily combined score

Alain Didier et al.

CLINICAL AND TRANSLATIONAL ALLERGY (2015)

Add to Collection

Article Allergy

Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: A randomized, double-blind, placebo-controlled trial

Holger Mosbech et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)

Add to Collection

Article Allergy

Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis

Karl-Christian Bergmann et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)

Add to Collection

Article Allergy

SQ-standardized sublingual grass immunotherapy: Confirmation of disease modification 2 years after 3 years of treatment in a randomized trial

Stephen R. Durham et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)

Add to Collection

Article Allergy

Allergen immunotherapy: A practice parameter third update

Linda Cox et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)

Add to Collection

Article Immunology

Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study

H. Ott et al.

ALLERGY (2009)

Add to Collection

Article Allergy

Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma:: 10-year follow-up on the PAT study

L. Jacobsen et al.

ALLERGY (2007)

Add to Collection

Review Allergy

Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce

G. W. Canonica et al.

ALLERGY (2007)

Add to Collection

Article Allergy

Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis

Ronald Dahl et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)

Add to Collection

Article Allergy

Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma

G Roberts et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)

Add to Collection

Article Allergy

Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis

AJ Frew et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)

Add to Collection

© Peeref 2019-2024. All rights reserved.